A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: The primary objective is to evaluate the efficacy of an inactivated and aluminium hydroxide adsorbed SARS-CoV-2 vaccine (Sinovac, China) in voluntary participants after 14 days of the second dose against RT-PCR confirmed symptomatic COVID-19 cases. The secondary objectives include evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Akova, Murat, Unal, Serhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042350/
https://www.ncbi.nlm.nih.gov/pubmed/33849629
http://dx.doi.org/10.1186/s13063-021-05180-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042350/
https://www.ncbi.nlm.nih.gov/pubmed/33849629
http://dx.doi.org/10.1186/s13063-021-05180-1

Ejemplares similares